1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. Keeping that in mind, here is one stock where you should be greedy instead of fearful and two where the outlook is warranted.
Two Stocks to Sell:
JELD-WEN (JELD)
Consensus Price Target: $1.93 (-11.7% implied return)
Founded in the 1960s as a general wood-making company, JELD-WEN (NYSE:JELD) manufactures doors, windows, and other related building products.
Why Are We Out on JELD?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
- Depletion of cash reserves could lead to a fundraising event that triggers shareholder dilution
At $2.19 per share, JELD-WEN trades at 9.4x forward EV-to-EBITDA. If you’re considering JELD for your portfolio, see our FREE research report to learn more.
Bausch + Lomb (BLCO)
Consensus Price Target: $18.63 (8.7% implied return)
With a nearly 170-year history dedicated to vision care and eye health innovation, Bausch + Lomb (NYSE:BLCO) develops and manufactures a comprehensive range of eye health products including contact lenses, pharmaceuticals, surgical devices, and consumer eye care solutions.
Why Are We Cautious About BLCO?
- Earnings per share have dipped by 18% annually over the past four years, which is concerning because stock prices follow EPS over the long term
- Free cash flow margin shrank by 7.6 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive
- Low returns on capital reflect management’s struggle to allocate funds effectively
Bausch + Lomb is trading at $17.13 per share, or 16.9x forward P/E. To fully understand why you should be careful with BLCO, check out our full research report (it’s free).
One Stock to Watch:
Marsh (MRSH)
Consensus Price Target: $207.10 (9% implied return)
With roots dating back to 1871 and a presence in over 130 countries, Marsh (NYSE:MRSH) is a global professional services firm that helps organizations manage risk, strategy, and workforce challenges through its four specialized businesses.
Why Could MRSH Be a Winner?
- Offerings and unique value proposition resonate with customers, as seen in its above-market 8.8% annual sales growth over the last two years
- Dominant market position is represented by its $27.95 billion in revenue and gives it fixed cost leverage when sales grow
- Strong free cash flow margin of 15.9% enables it to reinvest or return capital consistently, and its improved cash conversion implies it’s becoming a less capital-intensive business
Marsh’s stock price of $189.95 implies a valuation ratio of 17.6x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.